Skip to Content

Preoxygenation: noninvasive ventilation versus an oxygen mask

The PREOXI trial in 1,301 critically ill adults
November 4, 2026 by
“Join the OxyGENation” poster. Courtesy of PAC.
“Join the OxyGENation” poster. Courtesy of PAC.

Hypoxemia during intubation raises the risk of cardiac arrest and death in critically ill patients. The PREOXI trial asked whether preoxygenating with noninvasive ventilation (NIV) reduces it compared with the usual oxygen mask.

The study

A randomized, pragmatic, unblinded trial in 24 emergency departments and intensive care units in the United States with 1,301 adults (Gibbs et al., N Engl J Med 2024). The primary outcome was hypoxemia, defined as oxygen saturation below 85% between induction and 2 minutes after intubation.

Main results of the PREOXI trial
OutcomeNIVOxygen mask
Hypoxemia (SpO₂ < 85%)9.1% (57/624)18.5% (118/637)
Cardiac arrest0.2% (1 patient)1.1% (7 patients)
Aspiration0.9% (6)1.4% (9) · difference not significant

A limitation to keep in mind: because the trial was open-label and pragmatic, teams knew which technique they were using. Results should be weighed against each center's context, team and experience with NIV.

Taking it to training

Preoxygenation is a step of the procedure, not a formality: in simulation you can practice the setup, interface fit and team communication before induction.

Sources

Image: “Join the OxyGENation” poster, courtesy of PAC (The Protected Airway Collaborative).

Educational content; it does not replace clinical judgment or your institution's guidelines.

Video or direct laryngoscopy: what the DEVICE trial showed
A trial of 1,417 critically ill adults compared both devices on the first attempt